Yuhan set a new quarterly sales record. In the domestic market, both Rx and OTC drugs were strong, and overseas businesses were also doing well. Operating profit fell due to a decrease in technology fee revenue and an increase in R&D investment. Yuhan Corporation announced on the 28th that its operating profit based on separate financial statements in the second quarter fell 61.9% year-on-year to 10.8 billion won. Sales increased 10.4% year-on-year to 468 billion won. The company's second-quarter sales are the largest ever. It broke 439.4 billion won in the fourth quarter of 2020 for the first time in six quarters.

Both domestic demand and overseas business showed growth. In the domestic market, sales of t